Continuous subcutaneous infusion of morphine in a patient with advanced tumor dyspnea.
Case report and literature review.
DOI:
https://doi.org/10.35509/01239015.794Keywords:
dyspnea, neoplasm, opioids, infusion subcutaneousAbstract
A clinical case is presented in a patient with tumor dyspnea associated with an advanced and progressive oncological disease that requires symptomatic management and that required different pharmacological strategies, achieving greater benefit with the administration of opioids through continuous subcutaneous infusion. At the end, a review is made on the management of tumor dyspnea with emphasis on the usefulness of this type of strategy, comparing it with others available.
Author Biography
John Lidemberto Cardenas Cardenas, Hospital Pablo Tobon Uribe
M.D.M.D..Hospital Pablo Tobon Uribe, Dolor y Cuidados paliativos
References
Bruera E MT, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med. 1993;119:906-7.
Cohen MH AA, Krasnow SH, Spagnolo SV, Citron ML, Payne M, Fossieck BE. Continuous Intravenous Infusion of Morphine for Severe Dyspnea. South Med J. 1991;84(2):229-34.
Kim YH OC, Sakamori Y, Masago K, Togashi Y, Mishima M. Continuous morphine infusion for end-stage lung cancer patients. Oncol Lett. 2013;5(3):972-74.
Kawabata M, Kaneishi K. Continuous subcutaneous infusion of compound oxycodone for the relief of dyspnea in patients with terminally ill cancer: a retrospective study. Am J Hosp Palliat Care. 2013;30(3):305-11.
Vargas-Bermudez A, Cardenal F, Porta-Sales J. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review. J Pain Palliat Care Pharmacother. 2015;29(4):341-52.
Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3:CD011008.
Nelson KA GP, Walsh D, Groh ES. A Prospective, Within-Patient, Crossover Study of Continuous Intravenous and Subcutaneous Morphine for Chronic Cancer Pain. J Pain Symptom Manage. 1997;13(5):262-7.
Watanabe S, Pereira J, Tarumi Y, Hanson J, Bruera E. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. J Palliat Med. 2008;11(4):570-4.
Citron ML J-EA, Fossieck BE Jr, Krasnow SH, Franklin R, Spagnolo SV, Cohen MH., N. Safety and Efficacy of Continuous Intravenous Morphine for Severe Cancer Pain. Am J Med. 1984;77(2):199-204.
Benitez-Rosario MA, González IR, González-Dávila E, Sanz E. Fentanyl treatment for end-of-life dyspnea relief in advanced cancer patients. Support Care Cancer Online publlished https://doi.org/10.1007/s00520-018-4309-8
Logan M, Fothergill Bourbonnais F. Continuous Subcutaneous Infusion of Narcotics: An Exploratory Study of Patient, Family and Nursing Concerns. The Hospice J 1990; 61(1): 69-77
Moulin DE, Johnson NG, Murray-Parsons N, Geoghegan MF, Goodwin VA, Chester MA. Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use. CAN MED ASSOC J 1992; 146 (6): 891-897
Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD011008. DOI: 10.1002/14651858.CD011008.pub2.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
